[go: up one dir, main page]

PT100896A - PHARMACEUTICAL COMPOSITION FOR THE NEUTRALIZATION OF INTERLEUQUIN-1 (IL-1) USING DSRNA'S - Google Patents

PHARMACEUTICAL COMPOSITION FOR THE NEUTRALIZATION OF INTERLEUQUIN-1 (IL-1) USING DSRNA'S

Info

Publication number
PT100896A
PT100896A PT100896A PT10089692A PT100896A PT 100896 A PT100896 A PT 100896A PT 100896 A PT100896 A PT 100896A PT 10089692 A PT10089692 A PT 10089692A PT 100896 A PT100896 A PT 100896A
Authority
PT
Portugal
Prior art keywords
interleuquin
dsrna
neutralization
pharmaceutical composition
pharmaceutical
Prior art date
Application number
PT100896A
Other languages
Portuguese (pt)
Inventor
William A Carter
Original Assignee
Hem Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Pharma Corp filed Critical Hem Pharma Corp
Publication of PT100896A publication Critical patent/PT100896A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
PT100896A 1991-09-26 1992-09-24 PHARMACEUTICAL COMPOSITION FOR THE NEUTRALIZATION OF INTERLEUQUIN-1 (IL-1) USING DSRNA'S PT100896A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76636391A 1991-09-26 1991-09-26

Publications (1)

Publication Number Publication Date
PT100896A true PT100896A (en) 1993-10-29

Family

ID=25076210

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100896A PT100896A (en) 1991-09-26 1992-09-24 PHARMACEUTICAL COMPOSITION FOR THE NEUTRALIZATION OF INTERLEUQUIN-1 (IL-1) USING DSRNA'S

Country Status (8)

Country Link
EP (1) EP0654998A1 (en)
JP (1) JP2002514999A (en)
AU (1) AU2554792A (en)
CA (1) CA2120027A1 (en)
MX (1) MX9205366A (en)
PT (1) PT100896A (en)
WO (1) WO1993005788A1 (en)
ZA (1) ZA927308B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
US20100239632A1 (en) 2009-03-23 2010-09-23 Warsaw Orthopedic, Inc. Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
CN108445241B (en) 2010-06-20 2021-11-02 佐拉生物科学公司 Lipomics markers for identifying patients with high risk coronary artery disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795744A (en) * 1986-07-17 1989-01-03 Hem Research, Inc. Modulation of AIDS virus-related events by double-stranded RNAS
IE72103B1 (en) * 1987-08-12 1997-03-12 Hem Res Inc Promotion of host defense by systemic dsRNA treatment
DE3853755T2 (en) * 1987-09-04 1995-12-14 Hem Pharma Corp Diagnosis of deficiency states of double-stranded RNA.
DE69029737T2 (en) * 1989-10-16 1997-06-19 Hem Pharma Corp DIAGNOSIS AND TREATMENT OF NEURO-COGNITIVE DISORDERS ASSOCIATED WITH SYSTEMIC-IMMUNOLOGICAL MALFUNCTION

Also Published As

Publication number Publication date
EP0654998A4 (en) 1995-01-11
AU2554792A (en) 1993-04-27
MX9205366A (en) 1993-05-01
JP2002514999A (en) 2002-05-21
WO1993005788A1 (en) 1993-04-01
EP0654998A1 (en) 1995-05-31
ZA927308B (en) 1993-03-29
CA2120027A1 (en) 1993-04-01

Similar Documents

Publication Publication Date Title
FI934914A (en) PHARMACEUTICAL FORMULATION
DK481989A (en) PHARMACEUTICAL FORMULATIONS
DK0515312T3 (en) Pharmaceutical preparation
EE03108B1 (en) Pharmaceutical composition
FI981777A (en) Pharmaceutical composition
FI921060A (en) PHARMACEUTICAL AEROSOLFORMULERINGAR
FI923581A (en) PHARMACEUTICAL COMBINATIONSFORMATION
FR2636532B1 (en) PHARMACEUTICAL COMPOSITIONS
MX9200622A (en) PHARMACEUTICAL COMPOSITION
ITTO920303A0 (en) "ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION"
DE4294862T1 (en) Pharmaceutical composition
MX9200146A (en) SWALLOWABLE PHARMACEUTICAL COMPOSITIONS
UA26064A1 (en) PHARMACEUTICAL COMPOSITION
PT100896A (en) PHARMACEUTICAL COMPOSITION FOR THE NEUTRALIZATION OF INTERLEUQUIN-1 (IL-1) USING DSRNA'S
DK0511991T3 (en) Pharmaceutical formulation
DE69033790D1 (en) Photoresist composition
DK136492D0 (en) A PHARMACEUTICAL FORMULATION
ITMI912766A0 (en) PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CYSTEINE
SE9101348D0 (en) PHARMACEUTICAL COMPOSITION
SE9103213D0 (en) PHARMACEUTICAL COMPOSITION
BR7102348U (en) Lollipop for medical application
SE8904063D0 (en) PHARMACEUTICAL COMPOSITION
IT9020332A0 (en) PHARMACEUTICAL COMPOSITION
DK207590D0 (en) PHARMACEUTICAL PREPARATION
DK204190D0 (en) PHARMACEUTICAL PREPARATION

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930526

FC3A Refusal

Effective date: 19990503